Guía de práctica clínica: síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: concepto, diagnóstico y continuidad asistencial. (Parte 1 de 2)

[1]  S. Brown,et al.  Sacral nerve stimulation for faecal incontinence and constipation in adults , 2018, Techniques in Coloproctology.

[2]  J. Serra,et al.  Clinical practice guidelines for the management of constipation in adults. Part 2: Diagnosis and treatment ☆ ☆☆ , 2017 .

[3]  J. Serra,et al.  [Clinical practice guidelines for the management of constipation in adults. Part 1: Definition, aetiology and clinical manifestations]. , 2017 .

[4]  Juan Ferrándiz Santos,et al.  Clinical practice guidelines for the management of constipation in adults. Part 1: Definition, aetiology and clinical manifestations. , 2017, Gastroenterologia y hepatologia.

[5]  E. Rey,et al.  Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult. , 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[6]  S. Puli,et al.  Irritable Bowel Syndrome: A Clinical Review. , 2016, Current rheumatology reviews.

[7]  S. Rao,et al.  Systematic review: dietary fibre and FODMAP‐restricted diet in the management of constipation and irritable bowel syndrome , 2015, Alimentary pharmacology & therapeutics.

[8]  W. Whitehead,et al.  ANMS‐ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  L. Böhn,et al.  Mo1264 A Randomized, Controlled Trial Comparing a Diet Low in FODMAPs With Traditional Dietary Advice in Patients With IBS , 2015 .

[10]  S. Buckner,et al.  Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance , 2015, BMJ : British Medical Journal.

[11]  R. Schey,et al.  Lubiprostone in constipation: clinical evidence and place in therapy , 2015, Therapeutic advances in chronic disease.

[12]  M. Pescatori,et al.  Management of obstructed defecation. , 2015, World journal of gastroenterology.

[13]  G. Ringström,et al.  Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects. , 2015, World journal of gastroenterology.

[14]  K. Whelan,et al.  Systematic review: the effect of prunes on gastrointestinal function , 2014, Alimentary pharmacology & therapeutics.

[15]  P. Moayyedi,et al.  Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis , 2014, The American Journal of Gastroenterology.

[16]  P. Moayyedi,et al.  American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation , 2014, The American Journal of Gastroenterology.

[17]  L. Saha.  Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. , 2014, World journal of gastroenterology.

[18]  E. Rey,et al.  Chronic Constipation, Irritable Bowel Syndrome With Constipation and Constipation With Pain/Discomfort: Similarities and Differences , 2014, The American Journal of Gastroenterology.

[19]  C. Blandizzi,et al.  Understanding and treating refractory constipation. , 2014, World journal of gastrointestinal pharmacology and therapeutics.

[20]  M. Pimentel,et al.  Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome , 2014, Digestive Diseases and Sciences.

[21]  Y. Falck‐Ytter,et al.  Effect of linaclotide in irritable bowel syndrome with constipation (IBS‐C): a systematic review and meta‐analysis , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[22]  P. Chiarelli,et al.  Biofeedback for treatment of chronic idiopathic constipation in adults. , 2014, The Cochrane database of systematic reviews.

[23]  M. Camilleri,et al.  Systematic review with meta‐analysis: highly selective 5‐HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation , 2014, Alimentary pharmacology & therapeutics.

[24]  E. Videlock,et al.  Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  Jane G Muir,et al.  No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. , 2013, Gastroenterology.

[26]  A. Lembo,et al.  Diagnostic testing for dyssynergic defecation in chronic constipation: meta‐analysis , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[27]  Chun-Fang Xu,et al.  Effect of dietary fiber on constipation: a meta analysis. , 2012, World journal of gastroenterology.

[28]  M. Soresi,et al.  Non-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge: Exploring a New Clinical Entity , 2012, The American Journal of Gastroenterology.

[29]  F. Mearin,et al.  Diagnostic criteria in IBS: useful or not? , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[30]  K. Whelan,et al.  Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. , 2012, The Journal of nutrition.

[31]  L. Lao,et al.  Acupuncture for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis , 2012, The American Journal of Gastroenterology.

[32]  R. Felt-Bersma,et al.  Clinical examination remains more important than anorectal function tests to identify treatable conditions in women with constipation , 2012, International Urogynecology Journal.

[33]  M. Bellini,et al.  Consensus statement AIGO/SICCR: diagnosis and treatment of chronic constipation and obstructed defecation (part I: diagnosis). , 2012, World journal of gastroenterology.

[34]  E. Björnsson,et al.  Effects of Gut-Directed Hypnotherapy on IBS in Different Clinical Settings—Results From Two Randomized, Controlled Trials , 2012, The American Journal of Gastroenterology.

[35]  S. Clark,et al.  Systematic review of abdominal surgery for chronic idiopathic constipation , 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[36]  E. Rey,et al.  Translation, cultural adaptation and validation of a Spanish version of the Irritable Bowel Syndrome Severity Score. , 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[37]  M. Kamm,et al.  Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study , 2011, Alimentary pharmacology & therapeutics.

[38]  P. Whorwell,et al.  Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report , 2011, The American Journal of Gastroenterology.

[39]  M. Currie,et al.  Two randomized trials of linaclotide for chronic constipation. , 2011, The New England journal of medicine.

[40]  H. Mönnikes.  Quality of Life in Patients With Irritable Bowel Syndrome , 2011, Journal of clinical gastroenterology.

[41]  P. Clavé,et al.  Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome , 2011, Alimentary pharmacology & therapeutics.

[42]  M. Kamm,et al.  Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  M. Simrén,et al.  Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial , 2011, The American Journal of Gastroenterology.

[44]  G. Boeckxstaens,et al.  Diagnosis and treatment of chronic constipation – a European perspective , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[45]  M. Dibonaventura,et al.  Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey , 2011, Digestive Diseases and Sciences.

[46]  A. Ford,et al.  Systematic review: the effects of fibre in the management of chronic idiopathic constipation , 2011, Alimentary pharmacology & therapeutics.

[47]  S. Rao,et al.  What is necessary to diagnose constipation? , 2011, Best practice & research. Clinical gastroenterology.

[48]  W. Chey,et al.  Rifaximin therapy for patients with irritable bowel syndrome without constipation. , 2011, The New England journal of medicine.

[49]  A. Ford,et al.  Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis , 2011, Gut.

[50]  M. Currie,et al.  Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. , 2010, European journal of pharmacology.

[51]  B. Orkin,et al.  The Digital Rectal Examination Scoring System (DRESS) , 2010, Diseases of the colon and rectum.

[52]  M. Currie,et al.  Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. , 2010, Gastroenterology.

[53]  K. Tantiphlachiva,et al.  Digital rectal examination is a useful tool for identifying patients with dyssynergia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[54]  Santiago Camacho,et al.  A randomized, double‐blind, placebo‐controlled trial of polyethylene glycol effects on fasting and postprandial rectal sensitivity and symptoms in hypersensitive constipation‐predominant irritable bowel syndrome , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[55]  J. Armstrong,et al.  Are abdominal x-rays a reliable way to assess for constipation? , 2010, The Journal of urology.

[56]  W. Whitehead,et al.  Inability of the Rome III Criteria to Distinguish Functional Constipation From Constipation-Subtype Irritable Bowel Syndrome , 2010, The American Journal of Gastroenterology.

[57]  L. Fishman,et al.  Lack of Utility of Abdominal X-rays in the Evaluation of Children With Constipation: Comparison of Different Scoring Methods , 2010, Journal of pediatric gastroenterology and nutrition.

[58]  R. Nelson,et al.  Lactulose versus Polyethylene Glycol for Chronic Constipation. , 2010, The Cochrane database of systematic reviews.

[59]  S. Greenfield,et al.  Systematic review: impact of constipation on quality of life in adults and children , 2010, Alimentary pharmacology & therapeutics.

[60]  S M Scott,et al.  Wireless pH‐motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[61]  R. Malekzadeh,et al.  The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome , 2010, Digestive Diseases and Sciences.

[62]  Zengri J. Wang,et al.  Sacral nerve stimulation for intractable constipation , 2010, Gut.

[63]  M. Currie,et al.  Guanylate cyclase C‐mediated antinociceptive effects of linaclotide in rodent models of visceral pain , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[64]  M. Kamm,et al.  Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Sodium Picosulfate in Patients With Chronic Constipation , 2010, The American Journal of Gastroenterology.

[65]  W. Chey,et al.  Do Stool Form and Frequency Correlate With Whole-Gut and Colonic Transit? Results From a Multicenter Study in Constipated Individuals and Healthy Controls , 2010, The American Journal of Gastroenterology.

[66]  G. Eisen,et al.  Constipation is not associated with an increased rate of findings on colonoscopy: results from a national endoscopy consortium. , 2010, Endoscopy.

[67]  E. Tangalos,et al.  Chronic constipation in the elderly. , 2009, Gastroenterology clinics of North America.

[68]  A. Zinsmeister,et al.  Psychosocial Distress and Somatic Symptoms in Community Subjects With Irritable Bowel Syndrome: A Psychological Component Is the Rule , 2009, The American Journal of Gastroenterology.

[69]  B. P. Brennan,et al.  Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study , 2009, Human psychopharmacology.

[70]  Roger B. Davis,et al.  A Treatment Trial of Acupuncture in IBS Patients , 2009, The American Journal of Gastroenterology.

[71]  P. T. Dorsher,et al.  Puntos gatillo y puntos de acupuntura clásica. Parte 2: Correspondencias clínicas en el tratamiento del dolor y las disfunciones somatoviscerales , 2009 .

[72]  J. Everhart,et al.  Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. , 2009, Gastroenterology.

[73]  W. Chey,et al.  Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies , 2009, Alimentary pharmacology & therapeutics.

[74]  R. Kerstens,et al.  Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled study , 2009, Alimentary pharmacology & therapeutics.

[75]  W. Chey,et al.  An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome , 2008, The American Journal of Gastroenterology.

[76]  P. Moayyedi,et al.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.

[77]  R. Kerstens,et al.  Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives , 2008, Gut.

[78]  M. Camilleri,et al.  A placebo-controlled trial of prucalopride for severe chronic constipation. , 2008, The New England journal of medicine.

[79]  M. Heitkemper,et al.  Psychological distress and GI symptoms are related to severity of bloating in women with irritable bowel syndrome. , 2008, Research in nursing & health.

[80]  G. Lamberti,et al.  Treatment of neurogenic bowel dysfunction using transanal irrigation: a multicenter Italian study , 2008, Spinal Cord.

[81]  E. Blanchard,et al.  The role of stress in symptom exacerbation among IBS patients. , 2008, Journal of psychosomatic research.

[82]  Y. Yiannakou,et al.  Functional defecation disorder as a clinical subgroup of chronic constipation: Analysis of symptoms and physiological parameters , 2008, Scandinavian journal of gastroenterology.

[83]  W. Whitehead,et al.  Comorbidity in Irritable Bowel Syndrome , 2007, The American Journal of Gastroenterology.

[84]  S. Sawyer,et al.  Hypnotherapy for treatment of irritable bowel syndrome. , 2007, The Cochrane database of systematic reviews.

[85]  Jan Tack,et al.  Altered rectal perception in irritable bowel syndrome is associated with symptom severity. , 2007, Gastroenterology.

[86]  N. Hyman,et al.  Practice Parameters for the Evaluation and Management of Constipation , 2007, Diseases of the colon and rectum.

[87]  J. Johanson,et al.  Chronic constipation: a survey of the patient perspective , 2007, Alimentary pharmacology & therapeutics.

[88]  B. Zimmerman,et al.  Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[89]  D. Drossman,et al.  Randomized, Controlled Trial Shows Biofeedback to be Superior to Alternative Treatments for Patients with Pelvic Floor Dyssynergia-Type Constipation , 2007, Diseases of the colon and rectum.

[90]  J. Malagelada,et al.  Physical Activity and Intestinal Gas Clearance in Patients with Bloating , 2006, The American Journal of Gastroenterology.

[91]  S. Laurberg,et al.  A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. , 2006, Gastroenterology.

[92]  M. Swash,et al.  Rectal Hyposensitivity , 2012, Journal of neurogastroenterology and motility.

[93]  P. Enck,et al.  Functional anorectal disorders. , 2006, Gastroenterology.

[94]  L. Melton,et al.  Differences Between Painless and Painful Constipation Among Community Women , 2006, The American Journal of Gastroenterology.

[95]  W. Whitehead,et al.  Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. , 2006, Gastroenterology.

[96]  Jianpin Liu,et al.  Herbal medicines for treatment of irritable bowel syndrome. , 2006, The Cochrane database of systematic reviews.

[97]  J. Tack,et al.  A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome , 2005, Gut.

[98]  J. Kellow,et al.  Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome. , 2005, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[99]  R. Malekzadeh,et al.  The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study , 2005, Alimentary pharmacology & therapeutics.

[100]  W. Whitehead,et al.  Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. , 2005, Gastroenterology.

[101]  N. D. de Wit,et al.  Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. , 2005, The Cochrane database of systematic reviews.

[102]  G. P. van Berge‐Henegouwen,et al.  Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation , 2005, Scandinavian journal of gastroenterology.

[103]  F. Shanahan,et al.  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. , 2005, Gastroenterology.

[104]  G. Boeckxstaens,et al.  Tegaserod for the Treatment of Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Multinational Study , 2005, The American Journal of Gastroenterology.

[105]  C. Ihlebæk,et al.  Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications , 2004, Alimentary pharmacology & therapeutics.

[106]  J. Malagelada,et al.  Effects of physical activity on intestinal gas transit and evacuation in healthy subjects. , 2004, The American journal of medicine.

[107]  F. Mearin,et al.  Calidad de vida en los pacientes con síndrome del intestino irritable , 2004 .

[108]  A. Hoes,et al.  Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome , 2004, Alimentary pharmacology & therapeutics.

[109]  C. Koebnick,et al.  Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[110]  Henry C. Lin,et al.  Normalization of Lactulose Breath Testing Correlates With Symptom Improvement in Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Study , 2003, American Journal of Gastroenterology.

[111]  M. Lefkowitz,et al.  A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation , 2002, Alimentary pharmacology & therapeutics.

[112]  S. Folden.  Practice guidelines for the management of constipation in adults. , 2002, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.

[113]  U. Ladabaum,et al.  The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. , 2002, Gastrointestinal endoscopy.

[114]  H. El‐Serag,et al.  Health‐related quality of life among persons with irritable bowel syndrome: a systematic review , 2002, Alimentary pharmacology & therapeutics.

[115]  Scott Davidoff,et al.  Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms , 2000, American Journal of Gastroenterology.

[116]  M. Camilleri,et al.  Serotonin: a mediator of the brain–gut connection , 2000, American Journal of Gastroenterology.

[117]  G. Lindberg,et al.  Clinical value of symptom assessment in patients with constipation , 1999, Diseases of the colon and rectum.

[118]  R. Marmo,et al.  Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. , 1998, Hepato-gastroenterology.

[119]  Gran‐Hum Chen,et al.  Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: A prospective, randomized trial , 1997, Journal of Gastroenterology.

[120]  M. Camilleri,et al.  Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[121]  A. Klauser,et al.  Symptoms in chronic constipation , 1997, Diseases of the colon and rectum.

[122]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.

[123]  P. Whorwell,et al.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.

[124]  R. Andersson,et al.  The role of oral administration of oatmeal fermented by Lactobacillus reuteri R2LC on bacterial translocation after acute liver failure induced by subtotal liver resection in the rat. , 1995, Scandinavian journal of gastroenterology.

[125]  P. Whorwell,et al.  Bran and irritable bowel syndrome: time for reappraisal , 1994, The Lancet.

[126]  D. Brassart,et al.  Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. , 1994, Gut.

[127]  E. Soppi,et al.  Enhancement of the Circulating Antibody Secreting Cell Response in Human Diarrhea by a Human Lactobacillus Strain , 1992, Pediatric Research.

[128]  O. Ostergaard,et al.  [Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo]. , 1988, Ugeskrift for laeger.

[129]  J. Cummings,et al.  Mechanism of action of dietary fibre in the human colon , 1980, Nature.

[130]  G. Devroede,et al.  Barium enema in chronic constipation: is it meaningful? , 1978, Gastroenterology.

[131]  J. Maunsell,et al.  Consortium , 1978 .

[132]  K. Sugano,et al.  Evidence-based clinical practice guidelines for irritable bowel syndrome , 2014, Journal of Gastroenterology.

[133]  B. Lacy,et al.  Fecal Impaction , 2014, Current Gastroenterology Reports.

[134]  A. Lembo,et al.  American Gastroenterological Association medical position statement on constipation. , 2013, Gastroenterology.

[135]  M. Prasad,et al.  The health-related quality of life and economic burden of constipation , 2012, PharmacoEconomics.

[136]  M. Bellini,et al.  Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). , 2012, World journal of gastroenterology.

[137]  N. Talley.  Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation , 2009 .

[138]  P. Masand,et al.  A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. , 2009, Psychosomatics.

[139]  A. Zinsmeister,et al.  FUNCTIONAL BOWEL DISORDERS , 2007, The American Journal of Gastroenterology.

[140]  J. Barkin.  The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial , 2007 .

[141]  M. Kamm,et al.  Myths and Misconceptions About Chronic Constipation , 2005, The American Journal of Gastroenterology.

[142]  M. Mínguez,et al.  Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. , 2004, Gastroenterology.

[143]  B. Naliboff,et al.  Symptoms and physiology in severe chronic constipation , 1999, American Journal of Gastroenterology.

[144]  [Measurement of colonic transit time (total and segmental) with radiopaque markers. National reference values obtained in 192 healthy subjects. Spanish Group for the Study of Digestive Motility]. , 1998, Gastroenterology & hepatology.

[145]  A. Klauser,et al.  Clinical response to dietary fiber treatment of chronic constipation. , 1997, The American journal of gastroenterology.

[146]  I. Kodner,et al.  Anorectal disorders. , 1985, Clinical symposia.